Neuroligin-1/NLGN1 Protein, Mouse (HEK293, His)

Neuroligin-1 (NLGN1) protein promotes cell interactions with members of the neuroligin family, affecting synaptic function and signaling. It recruits and aggregates synaptic proteins, promotes synapse formation and specifies excitatory synapses. Neuroligin-1/NLGN1 Protein, Mouse (HEK293, His) is the recombinant mouse-derived Neuroligin-1/NLGN1 protein, expressed by HEK293 , with C-His labeled tag.

Neuroligin-1 (NLGN1) Protein, a cell surface protein, actively engages in cell-cell interactions through its interactions with neurexin family members. This protein plays a pivotal role in synapse function and synaptic signal transmission, potentially mediating its effects by recruiting and clustering other synaptic proteins. While NLGN1 may contribute to the initial formation of synapses, it is not deemed essential for this process. In vitro studies demonstrate its ability to trigger the de novo formation of presynaptic structures, highlighting its involvement in the specification of excitatory synapses. Beyond synapse dynamics, NLGN1 is crucial for maintaining the quality of wakefulness and the normal synchrony of cerebral cortex activity during wakefulness and sleep. Its intricate interactions involve neurexins NRXN1, NRXN2, and NRXN3, with the binding facilitated by heparan sulfate glycan modification on neurexin. Additionally, NLGN1 interacts with DLG4/PSD-95 and exhibits associations with AIP1, GOPC, PDZRN3, and NLGN3, emphasizing its diverse roles in nervous system development and synaptic regulation.

Measured by its binding ability in a functional ELISA. When recombinant Mouse Neuroligin 1 is immobilized at 10 μg/mL can bind biotinylated human Neurexin 1 beta. The KD is 6.095 nM.

Mouse

HEK293

C-10*His

Q99K10-1 (Q46-S697)

192167

Extracellular Domain

QKLDDVDPLVTTNFGKIRGIKKELNNEILGPVIQFLGVPYAAPPTGEHRFQPPEPPSPWSDIRNATQFAPVCPQNIIDGRLPEVMLPVWFTNNLDVVSSYVQDQSEDCLYLNIYVPTEDGPLTKKHTDDLGDNDGAEDEDIRDSGGPKPVMVYIHGGSYMEGTGNLYDGSVLASYGNVIVITVNYRLGVLGFLSTGDQAAKGNYGLLDLIQALRWTSENIGFFGGDPLRITVFGSGAGGSCVNLLTLSHYSEGNRWSNSTKGLFQRAIAQSGTALSSWAVSFQPAKYARILATKVGCNVSDTVELVECLQKKPYKELVDQDVQPARYHIAFGPVIDGDVIPDDPQILMEQGEFLNYDIMLGVNQGEGLKFVENIVDSDDGVSASDFDFAVSNFVDNLYGYPEGKDVLRETIKFMYTDWADRHNPETRRKTLLALFTDHQWVAPAVATADLHSNFGSPTYFYAFYHHCQTDQVPAWADAAHGDEVPYVLGIPMIGPTELFPCNFSKNDVMLSAVVMTYWTNFAKTGDPNQPVPQDTKFIHTKPNRFEEVAWTRYSQKDQLYLHIGLKPRVKEHYRANKVNLWLELVPHLHNLNDISQYTSTTTKVPSTDITLRPTRKNSTPVTSAFPTAKQDDPKQQPSPFSVDQRDYSTELS

Approximately 80-125 kDa due to the glycosylation.

≥ 95%, as determined by reducing SDS-PAGE.

Lyophilized powder.

Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.

<1 EU/μg, determined by LAL method.

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH₂O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).

Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Room temperature in continental US; may vary elsewhere.